Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$80.93 - $108.63 $10,035 - $13,470
-124 Reduced 33.79%
243 $25,000
Q3 2022

Oct 31, 2022

SELL
$82.16 - $96.94 $903 - $1,066
-11 Reduced 2.91%
367 $31,000
Q2 2022

Aug 09, 2022

SELL
$71.48 - $86.85 $14,653 - $17,804
-205 Reduced 35.16%
378 $32,000
Q1 2022

Apr 26, 2022

SELL
$74.28 - $92.69 $5,645 - $7,044
-76 Reduced 11.53%
583 $45,000
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $47,263 - $60,278
659 New
659 $58,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.